The European Medicines Agency (EMA) is calling on marketing authorisation holders issued at central or national level to register their ‘Industry Single Point of Contact’ (i-SPOC) by 2 September.
Through their i-SPOC, pharmaceutical companies will inform the Agency of stock levels, possible tensions or shortages of their critical medicines in case of health emergencies or major events. Registration is a two-step process via the EMA’s secure IRIS platform.
As part of its strengthened...